XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Condensed Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Sep. 30, 2023   6,105      
Beginning balance at Sep. 30, 2023 $ 34,335 $ 6,105 $ 11,626 $ 23,264 $ (6,660)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (4,801)     (5,012) 211
Performance and restricted share expense 171   171    
Share transactions under equity-based plans (in shares)   85      
Share transactions under equity-based plans (49) $ 85 (134)    
Ending balance (in shares) at Mar. 31, 2024   6,190      
Ending balance at Mar. 31, 2024 29,656 $ 6,190 11,663 18,252 (6,449)
Beginning balance (in shares) at Dec. 31, 2023   6,160      
Beginning balance at Dec. 31, 2023 31,247 $ 6,160 11,609 19,842 (6,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (1,675)     (1,590) (85)
Performance and restricted share expense 84   84    
Share transactions under equity-based plans (in shares)   30      
Share transactions under equity-based plans 0 $ 30 (30)    
Ending balance (in shares) at Mar. 31, 2024   6,190      
Ending balance at Mar. 31, 2024 $ 29,656 $ 6,190 11,663 18,252 (6,449)
Beginning balance (in shares) at Sep. 30, 2024 6,158 6,158      
Beginning balance at Sep. 30, 2024 $ 30,425 $ 6,158 11,775 17,881 (5,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income 1,889     (3,708) 5,597
Performance and restricted share expense 87   87    
Share transactions under equity-based plans (in shares)   32      
Share transactions under equity-based plans $ (34) $ 32 (66)    
Ending balance (in shares) at Mar. 31, 2025 6,190 6,190      
Ending balance at Mar. 31, 2025 $ 32,367 $ 6,190 11,796 14,173 208
Beginning balance (in shares) at Dec. 31, 2024   6,147      
Beginning balance at Dec. 31, 2024 33,676 $ 6,147 11,778 15,565 186
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (1,370)     (1,392) 22
Performance and restricted share expense 67   67    
Share transactions under equity-based plans (in shares)   43      
Share transactions under equity-based plans $ (6) $ 43 (49)    
Ending balance (in shares) at Mar. 31, 2025 6,190 6,190      
Ending balance at Mar. 31, 2025 $ 32,367 $ 6,190 $ 11,796 $ 14,173 $ 208